Literature DB >> 18026828

Oxidative stress in plasma from maple syrup urine disease patients during treatment.

Alethéa G Barschak1, Angela Sitta, Marion Deon, Amanda T Barden, Carlos S Dutra-Filho, Moacir Wajner, Carmen R Vargas.   

Abstract

Maple Syrup Urine Disease (MSUD) is an autosomal recessive metabolic disorder caused by a deficiency of branched-chain alpha-keto acid dehydrogenase complex activity leading to accumulation of the branched-chain amino acids leucine, isoleucine and valine and their corresponding branched-chain alpha-keto acids. Affected patients usually present hypoglycemia, ketoacidosis, convulsions, poor feeding, coma, psychomotor delay and mental retardation. Considering that the pathophysiology of MSUD is still poorly understood, in this study we evaluated some parameters of oxidative stress, namely thiobarbituric acid-reactive substances (TBARS), total antioxidant reactivity (TAR) and total antioxidant status (TAS) in plasma from treated MSUD patients presenting high and low plasma leucine levels. We verified a significant increase of TBARS (lipid peroxidation) and a decrease of TAR (capacity to rapidly react with free radicals) in plasma from treated MSUD patients with low and with high plasma levels of leucine compared to the control group. It was also verified that TAS (quantity of tissue antioxidants) was not altered in plasma from treated MSUD patients with low and high blood leucine levels. Finally, we found no correlation between leucine, valine and isoleucine levels with the various parameters of oxidative stress. These results are indicative that increased lipid oxidative damage and decreased antioxidant defenses occur in plasma of MSUD patients and that the accumulating branched-chain amino acids are probably not directly associated to oxidative stress in this disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18026828     DOI: 10.1007/s11011-007-9077-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  33 in total

1.  Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.

Authors:  R G Tavares; C E Santos; C I Tasca; M Wajner; D O Souza; C S Dutra-Filho
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

2.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements.

Authors:  E Lissi; M Salim-Hanna; C Pascual; M D del Castillo
Journal:  Free Radic Biol Med       Date:  1995-02       Impact factor: 7.376

4.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.

Authors:  N J Miller; C Rice-Evans; M J Davies; V Gopinathan; A Milner
Journal:  Clin Sci (Lond)       Date:  1993-04       Impact factor: 6.124

5.  Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.

Authors:  M Wajner; D M Coelho; A G Barschak; P R Araújo; R F Pires; F L Lulhier; C R Vargas
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

6.  Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: alpha-ketoisocaproate infusion.

Authors:  H R Zielke; Y Huang; J T Tildon; C L Zielke; P J Baab
Journal:  Dev Neurosci       Date:  1996       Impact factor: 2.984

7.  Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.

Authors:  Alethéa G Barschak; Angela Sitta; Marion Deon; Marcella H de Oliveira; Alexsandro Haeser; Carlos S Dutra-Filho; Moacir Wajner; Carmen R Vargas
Journal:  Metab Brain Dis       Date:  2006-11-08       Impact factor: 3.584

8.  Effect of leucine administration on creatine kinase activity in rat brain.

Authors:  Carmen Pilla; Rui Felipe de Oliveira Cardozo; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2003-03       Impact factor: 3.584

9.  Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy.

Authors:  C R Vargas; M Wajner; L R Sirtori; L Goulart; M Chiochetta; D Coelho; A Latini; S Llesuy; A Bello-Klein; R Giugliani; M Deon; C F Mello
Journal:  Biochim Biophys Acta       Date:  2004-01-20

Review 10.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

View more
  22 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  Neuroprotective Effect of Creatine and Pyruvate on Enzyme Activities of Phosphoryl Transfer Network and Oxidative Stress Alterations Caused by Leucine Administration in Wistar Rats.

Authors:  Elenara Rieger; Itiane Diehl de Franceschi; Thales Preissler; Clovis Milton Duval Wannmacher
Journal:  Neurotox Res       Date:  2017-06-13       Impact factor: 3.911

3.  Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Authors:  Burcu Kumru; Davut Sinan Kaplan; Burcu Oztürk Hismi; Hakim Celik
Journal:  Cell Mol Neurobiol       Date:  2017-12-28       Impact factor: 5.046

4.  Investigation of L - Carnitine Concentrations in Treated Patients with Maple Syrup Urine Disease.

Authors:  Burcu Kumru; Burcu Oztürk Hismi
Journal:  J Pediatr Genet       Date:  2019-05-28

5.  Evaluation of dynamic thiol/disulphide homeostasis as a novel indicator of oxidative stress in maple syrup urine disease patients under treatment.

Authors:  Tanyel Zubarioglu; Ertugrul Kiykim; Mehmet Serif Cansever; Salim Neselioglu; Cigdem Aktuglu-Zeybek; Ozcan Erel
Journal:  Metab Brain Dis       Date:  2016-08-18       Impact factor: 3.584

6.  Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.

Authors:  Luciane Taschetto; Giselli Scaini; Hugo G Zapelini; Ândrea C Ramos; Giulia Strapazzon; Vanessa M Andrade; Gislaine Z Réus; Monique Michels; Felipe Dal-Pizzol; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-05-27       Impact factor: 3.584

Review 7.  Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects.

Authors:  Ina Knerr; Natalie Weinhold; Jerry Vockley; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2011-02-03       Impact factor: 4.982

8.  Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuk; Gustavo C Ferreira; Joao Seda Neto; Tatiana Amorin; Ida Vanessa D Schwartz; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

9.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

Review 10.  "Classical organic acidurias": diagnosis and pathogenesis.

Authors:  Guglielmo Rd Villani; Giovanna Gallo; Emanuela Scolamiero; Francesco Salvatore; Margherita Ruoppolo
Journal:  Clin Exp Med       Date:  2016-09-09       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.